Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Return on Capital Employed (2020 - 2025)

Historic Return on Capital Employed for Revolution Medicines (RVMD) over the last 6 years, with Q3 2025 value amounting to 0.49%.

  • Revolution Medicines' Return on Capital Employed fell 1000.0% to 0.49% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.49%, marking a year-over-year decrease of 1000.0%. This contributed to the annual value of 0.32% for FY2024, which is 600.0% up from last year.
  • According to the latest figures from Q3 2025, Revolution Medicines' Return on Capital Employed is 0.49%, which was down 1000.0% from 0.41% recorded in Q2 2025.
  • In the past 5 years, Revolution Medicines' Return on Capital Employed registered a high of 0.19% during Q2 2021, and its lowest value of 0.49% during Q3 2025.
  • Its 5-year average for Return on Capital Employed is 0.33%, with a median of 0.34% in 2024.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first plummeted by -1900bps in 2022, then skyrocketed by 600bps in 2023.
  • Over the past 5 years, Revolution Medicines' Return on Capital Employed (Quarter) stood at 0.28% in 2021, then decreased by -23bps to 0.34% in 2022, then fell by -4bps to 0.35% in 2023, then increased by 2bps to 0.35% in 2024, then crashed by -43bps to 0.49% in 2025.
  • Its Return on Capital Employed was 0.49% in Q3 2025, compared to 0.41% in Q2 2025 and 0.34% in Q1 2025.